Literature DB >> 17906843

A case of hyper-reactive malarial splenomegaly. The role of rapid antigen-detecting and PCR-based tests.

B Mothe1, J Lopez-Contreras, O H Torres, C Muñoz, P Domingo, M Gurgui.   

Abstract

Hyper-reactive malarial splenomegaly (HMS) - originally referred to as tropical splenomegaly syndrome - is characterized by a massive splenomegaly, high titres of anti-malarial antibodies and polyclonal IgM hypergammaglobulinemia. It is believed to be a consequence of an aberrant immunological response to prolonged exposure to malarial parasites. Although it is a frequent disease in the tropics, it is infrequent in western countries and is only seen in long-term residents from endemic areas. We describe the case of a 67-year-old Spanish man, a missionary in Cameroon for 30 years, who presented with a clinical history that fulfilled the diagnosis of HMS. We discuss the role and importance of PCR-based techniques in demonstrating lowgrade malarial parasitemia and the usefulness of new rapid antigen-detecting dipstick tests.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906843     DOI: 10.1007/s15010-007-6025-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  HMS-related hemolysis after acute attacks of Plasmodium vivax malaria.

Authors:  Oriol Mitjà; Russell Hays; James Malken; Anthony Ipai; Samson Kangapu; Jenny Robson; Quique Bassat
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

2.  Case Report: Hyperreactive Malarial Splenomegaly Syndrome Diagnosed with Loop-Mediated Isothermal Amplification and Treated with Artemisinin-Based Combination Therapy.

Authors:  Francesco G Genderini; Cecile Haeseleer; Brigitte Cantinieaux; Charlotte Martin
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

Review 3.  The hyper-reactive malarial splenomegaly: a systematic review of the literature.

Authors:  Stefania Leoni; Dora Buonfrate; Andrea Angheben; Federico Gobbi; Zeno Bisoffi
Journal:  Malar J       Date:  2015-04-29       Impact factor: 2.979

4.  Treatment of suspected hyper-reactive malarial splenomegaly (HMS) in pregnancy with mefloquine.

Authors:  Juthamas Jaroensuk; Nicole Stoesser; Mara L Leimanis; Podjanee Jittamala; Nicholas J White; Francois H Nosten; Rose McGready
Journal:  Am J Trop Med Hyg       Date:  2014-03-03       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.